Challenges in the Discovery of Novel Therapeutic Agents in Cancer

Author(s): Ganji Purnachandra Nagaraju, Mohammad Amjad Kamal

Journal Name: Current Drug Metabolism

Volume 20 , Issue 13 , 2019

Become EABM
Become Reviewer

[1]
MacConaill, L.E.; Garraway, L.A. Clinical implications of the cancer genome. J. Clin. Oncol., 2010, 28(35), 5219.
[2]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2019. CA , 2019, 69(1), 7-34.
[3]
Mansoori, B.; Mohammadi, A.; Davudian, S.; Shirjang, S.; Baradaran, B. The different mechanisms of cancer drug resistance: a brief review. Adv. Pharma. Bull., 2017, 7(3), 339.
[4]
Kim, M.H.; Kim, S-H.; Yang, W.M. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimerʼs disease. Planta Med., 2014, 80(15), 1249-1258.
[5]
Kim, H-J.; Kim, S-K.; Kim, B-S.; Lee, S-H.; Park, Y-S.; Park, B-K.; Kim, S-J.; Kim, J.; Choi, C.; Kim, J-S. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J. Agric. Food Chem., 2010, 58(15), 8643-8650.
[6]
Venkatesan, R.; Ji, E.; Kim, S.Y. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review. Biomed.Res. Int., 2015. 2015
[7]
Mondal, P.J .N.; Kamal, M.; Meeran, S. Non-coding RNAs in lung cancer chemoresistance. Curr. Drug Metabol, 2020, 21.


promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 13
Year: 2019
Published on: 23 January, 2020
Page: [1004 - 1005]
Pages: 2
DOI: 10.2174/138920022013200123122311

Article Metrics

PDF: 24
HTML: 4
EPUB: 1
PRC: 1